- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03325179
A Clinical Trial of Thread-embedding Therapy at Acupuncture Point for Simple Obesity
October 26, 2017 updated by: Shanghai University of Traditional Chinese Medicine
A Clinical Trial of Acupoint Thread-embedding Therapy for Simple Obesity
Thread-embedding Therapy has been used for treating Obesity in recent years.
This research is aimed to observe the clinical effect of thread-embedding therapy in treating Simple Obesity.
One hundred patients is planned to be enrolled in the research and receive a thread-embedding therapy.
The level of BMI, serum triglyceride, cholesterol and fasting blood glucose will be adopted for evaluation before and after therapy.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Each participant will receive thread-embedding therapy every two weeks, and eight times in all.Blood test will be taken at the beginning of the first week of the whole therapy, and at the end of the 8th therapy.
During the periods of whole therapy, the participants shall follow diets control and physical exercise as the protocol described.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Institute of Digestive Diseases of Longhua Hospital affiliate to Shanghai University of Traditional Chinese Medicine
-
Contact:
- Guang Ji
- Phone Number: 9503 +86-64385700
- Email: jiliver@vip.sina.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with age from 18 to 60 years old;
- patients with BMI≥ 24, meanwhile waist more than 85 cm (for male) or 80 cm (for female);
- patients with diagnosed as central adiposity and/or Simple obesity according to the diagnosis criteria;
- patients who is willing to cooperate with the test treatment and signed informed consent.
Exclusion Criteria:
- Pregnant or lactating women;
- patients who Syncope after acupuncture;
- patients who present hypersensitivity reactions after acupoint-embedding therapy;
- patients with serious heart, liver, kidney, brain and other diseases;
- patients with severe primary diseases;
- patients with psychiatric diseases;
- patients who did not meet the criteria for the inclusion criteria while investigators find out during the trial;
- participants who did not complete dietary control and physical exercise as the protocol described.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: participants received treatment
100 participants who are diagnosed as simple obesity under the standards of... are planned to enrolled in the trial.
Each will receive Thread-embedding therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change Body Weight
Time Frame: participants will receive Thread-embedding Therapy twice a week lasting for 16 weeks subsequently.8 times in all.
|
a 5 percent of loss of body weight will be judged as effective
|
participants will receive Thread-embedding Therapy twice a week lasting for 16 weeks subsequently.8 times in all.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effection on cholesterol
Time Frame: Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
|
a target examined by blood test, in order to compare the Lipid metabolism
|
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
|
|
The effection on triglyceride
Time Frame: Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
|
a target examined by blood test, in order to compare the Lipid metabolism
|
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
|
|
The effection on fasting blood glucose
Time Frame: Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
|
to compare the level of glucose in order to get the message of improvement of blood glucose disorder by our therapy.
|
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2017
Primary Completion (Anticipated)
December 31, 2017
Study Completion (Anticipated)
March 31, 2018
Study Registration Dates
First Submitted
September 3, 2017
First Submitted That Met QC Criteria
October 26, 2017
First Posted (Actual)
October 30, 2017
Study Record Updates
Last Update Posted (Actual)
October 30, 2017
Last Update Submitted That Met QC Criteria
October 26, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- shutcmidd
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Loss
-
United States Army Research Institute of Environmental...USDA Grand Forks Human Nutrition Research Center; Eastern Michigan UniversityCompletedWeight Loss | Bone Loss | Muscle LossUnited States
-
Case Comprehensive Cancer CenterUniversity Hospitals Seidman Cancer CenterRecruitingUnintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking CombinUnintended Weight LossUnited States
-
HealthPartners InstituteNational Cancer Institute (NCI)Completed
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
Power Life Sciences Inc.Not yet recruitingGastric Bypass | Weight Loss Surgery
-
Medical University of ViennaCompleted
-
University at BuffaloHarvard Medical School (HMS and HSDM)TerminatedWeight Loss | Appetite LossUnited States
-
Duke UniversityNational Institute on Aging (NIA)Completed
-
Drexel UniversityUniversity of PennsylvaniaCompletedObesity | Overweight | Weight Loss MaintenanceUnited States
Clinical Trials on Thread-embedding Therapy
-
Indonesia UniversityNot yet recruiting
-
Shanghai Municipal Hospital of Traditional Chinese...Recruiting
-
Beijing Hospital of Traditional Chinese MedicineRecruiting
-
Indonesia UniversityNot yet recruiting
-
Loc Cong Dai Tran, MDSchool of Medicine - Vietnam National University at Ho Chi Minh city; Traditional...Completed
-
Indonesia UniversityCompletedQuality of Life | Post Operative Pain, Acute | Renal Transplant Donor of Left Kidney | Acupuncture AnalgesiaIndonesia
-
Indonesia UniversityCompletedMyofascial Pain of Upper Trapezius MuscleIndonesia
-
Kyunghee University Medical CenterKyung Hee University Hospital at Gangdong; DongGuk University; Daegu Korean Medicine...CompletedLumbar Disc HerniationKorea, Republic of
-
Northern Jiangsu People's HospitalRecruitingColorectal Cancer | Postoperative Ileus | LARS - Low Anterior Resection SyndromeChina
-
Indonesia UniversityCompletedWrinkle | Aging ProblemsIndonesia